An open label, multi-centre, prospective study to demonstrate safety and efficacy of once daily Advagraf in patients undergoing kidney or liver transplantation in India.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Tacrolimus (Primary) ; Immunosuppressants
- Indications Liver transplant rejection; Renal transplant rejection
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Astellas Pharma
- 10 Jun 2017 Biomarkers information updated
- 05 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 22 Aug 2012 Planned End Date 31 Jan 2013 added as reported by Clinical Trial Registry - India record.